Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

53

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Targeting conserved TIM3+VISTA+ tumor-associated macrophages overcomes resistance to cancer immunotherapy

Targeting conserved TIM3+VISTA+ tumor-associated macrop...

28

Advanced multiparametric image spectroscopy and super-resolution microscopy reveal a minimal model of CD95 signal initiation

Advanced multiparametric image spectroscopy and super-r...

52

The mitochondrial mRNA-stabilizing protein SLIRP regulates skeletal muscle mitochondrial structure and respiration by exercise-recoverable mechanisms

The mitochondrial mRNA-stabilizing protein SLIRP regula...

51